ES2991898T3 - Derivado de piperidina con puente ópticamente activo - Google Patents

Derivado de piperidina con puente ópticamente activo Download PDF

Info

Publication number
ES2991898T3
ES2991898T3 ES19846598T ES19846598T ES2991898T3 ES 2991898 T3 ES2991898 T3 ES 2991898T3 ES 19846598 T ES19846598 T ES 19846598T ES 19846598 T ES19846598 T ES 19846598T ES 2991898 T3 ES2991898 T3 ES 2991898T3
Authority
ES
Spain
Prior art keywords
compound
independently
alkyl
thieno
diazaspiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19846598T
Other languages
English (en)
Spanish (es)
Inventor
Seiji Kamioka
Naoaki Shimada
Hitoshi Ban
Kazuto Yamazaki
Akihiko Arakawa
Wataru Hirose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Sumitomo Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd, Sumitomo Pharma Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2991898T3 publication Critical patent/ES2991898T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES19846598T 2018-08-08 2019-08-07 Derivado de piperidina con puente ópticamente activo Active ES2991898T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018149547 2018-08-08
PCT/JP2019/031132 WO2020032105A1 (ja) 2018-08-08 2019-08-07 光学活性な架橋型ピペリジン誘導体

Publications (1)

Publication Number Publication Date
ES2991898T3 true ES2991898T3 (es) 2024-12-05

Family

ID=69414766

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19846598T Active ES2991898T3 (es) 2018-08-08 2019-08-07 Derivado de piperidina con puente ópticamente activo

Country Status (7)

Country Link
US (1) US20210198283A1 (https=)
EP (1) EP3835304B1 (https=)
JP (1) JP7352551B2 (https=)
CN (1) CN112771055B (https=)
CA (1) CA3108449A1 (https=)
ES (1) ES2991898T3 (https=)
WO (1) WO2020032105A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7618567B2 (ja) * 2019-09-27 2025-01-21 住友ファーマ株式会社 架橋型光学活性２級アミン誘導体
EP4263535A1 (en) 2020-12-17 2023-10-25 Astrazeneca AB N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides
IL313033A (en) * 2021-12-03 2024-07-01 Bionova Pharmaceuticals Shanghai Ltd Carbonyl substituted diazaspiro compounds and its use
CN116693546B (zh) * 2022-01-28 2025-06-27 成都先导药物开发股份有限公司 Menin抑制剂及其用途
CN120529900A (zh) 2022-11-24 2025-08-22 奥莱松基因组股份有限公司 用于治疗癌症的LSD1抑制剂和Menin抑制剂的组合
WO2025023321A1 (en) * 2023-07-27 2025-01-30 Sumitomo Pharma Co., Ltd. Process for preparing optically-active azabicyclo ring derivative, and intermediate for its production

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200528440A (en) 2003-10-31 2005-09-01 Fujisawa Pharmaceutical Co 2-cyanopyrrolidinecarboxamide compound
WO2014164543A1 (en) * 2013-03-13 2014-10-09 The Regents Of The University Of Michigan Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
AU2016378579A1 (en) 2015-12-22 2018-06-14 Vitae Pharmaceuticals, Inc. Inhibitors of the menin-MLL interaction
WO2017207387A1 (en) * 2016-05-31 2017-12-07 Bayer Pharma Aktiengesellschaft Spiro condensed azetidine derivatives as inhibitors of the menin-mml1 interaction
WO2018024602A1 (en) * 2016-08-04 2018-02-08 Bayer Aktiengesellschaft 2,7-diazaspiro[4.4]nonanes
CA3033239A1 (en) * 2016-09-14 2018-03-22 Janssen Pharmaceutica Nv Spiro bicyclic inhibitors of menin-mll interaction
CA3033020A1 (en) * 2016-09-14 2018-03-22 Janssen Pharmaceutica Nv Fused bicyclic inhibitors of menin-mll interaction
US11325921B2 (en) * 2018-03-30 2022-05-10 Sumitomo Dainippon Pharma Co., Ltd. Optically active crosslinked cyclic secondary amine derivative
KR102779601B1 (ko) * 2018-08-27 2025-03-12 스미토모 파마 가부시키가이샤 광학 활성인 아자비시클로환 유도체

Also Published As

Publication number Publication date
JP7352551B2 (ja) 2023-09-28
EP3835304A4 (en) 2022-06-08
WO2020032105A1 (ja) 2020-02-13
EP3835304A1 (en) 2021-06-16
CN112771055A (zh) 2021-05-07
CA3108449A1 (en) 2020-02-13
JPWO2020032105A1 (ja) 2021-08-12
CN112771055B (zh) 2023-10-20
EP3835304B1 (en) 2024-10-09
US20210198283A1 (en) 2021-07-01

Similar Documents

Publication Publication Date Title
US12263167B2 (en) Optically active azabicyclo ring derivative
ES2991898T3 (es) Derivado de piperidina con puente ópticamente activo
US12559487B2 (en) Crosslinked optically active secondary amine derivative
CN112105621B (zh) 光学活性桥型环状仲胺衍生物
US10815241B2 (en) Optically active azabicyclo ring derivative
WO2023151635A1 (zh) 基于喹唑啉取代戊二酰亚胺骨架的化合物及其应用
HK40053381A (en) Optically active bridged piperidine derivative
HK40053381B (en) Optically active bridged piperidine derivative
HK40043242B (zh) 光学活性桥型环状仲胺衍生物
HK40055661A (en) Optically active azabicyclic derivative
EA041780B1 (ru) Оптически активное азабициклическое производное
HK40043242A (en) Optically active crosslinked cyclic secondary amine derivative